|
C10ORF18 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.364250E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.874000E-01 |
| Normal-vs-Stage2 |
9.158000E-01 |
| Normal-vs-Stage3 |
3.277400E-01 |
| Normal-vs-Stage4 |
2.301600E-01 |
| Stage1-vs-Stage2 |
6.311800E-01 |
| Stage1-vs-Stage3 |
4.785600E-01 |
| Stage1-vs-Stage4 |
4.696000E-01 |
| Stage2-vs-Stage3 |
3.544200E-01 |
| Stage2-vs-Stage4 |
2.348200E-01 |
| Stage3-vs-Stage4 |
8.246200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.282200E-01 |
| Normal-vs-AfricanAmerican |
3.206200E-01 |
| Normal-vs-Asian |
1.467780E-01 |
| Caucasian-vs-AfricanAmerican |
6.094000E-01 |
| Caucasian-vs-Asian |
2.138400E-01 |
| AfricanAmerican-vs-Asian |
3.412400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.834000E-01 |
| Normal-vs-Female |
6.757500E-03 |
| Male-vs-Female |
1.047720E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.948000E-01 |
| Normal-vs-Extreme_Weight |
7.610600E-01 |
| Normal-vs-Obese |
1.146760E-01 |
| Normal-vs-Extreme_Obese |
6.380000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.074800E-01 |
| Normal_Weight-vs-Obese |
1.111800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.610800E-01 |
| Extreme_Weight-vs-Obese |
9.816300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.167000E-01 |
| Obese-vs-Extreme_Obese |
2.597200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.375700E-03 |
| Normal-vs-Age(41-60Yrs) |
7.659200E-03 |
| Normal-vs-Age(61-80Yrs) |
4.961800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.799900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.032100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.374800E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.953590E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.350700E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.756000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.186790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.478020E-01 |
| Normal-VS-Type2 PRCC |
1.995040E-01 |
| Normal-VS-KIRP CIMP |
2.131600E-02 |
| Normal-VS-Unclassified PRCC |
1.464600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.653630E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.329800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.270800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.201900E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.974360E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.556580E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.009200E-01 |
| Normal-vs-N1 |
4.065700E-02 |
| Normal-vs-N2 |
7.327800E-01 |
| N0-vs-N1 |
1.911760E-02 |
| N0-vs-N2 |
4.147200E-01 |
| N1-vs-N2 |
6.260600E-01 |
|
|
